Annual Interest Coverage Ratio
N/A
31 December 2023
Summary:
XTL Biopharmaceuticals annual interest coverage ratio is not available.XTLB Interest Coverage Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Interest Coverage Ratio
31.31
0.00%
31 March 2024
Summary:
XTL Biopharmaceuticals quarterly interest coverage ratio is currently 31.31Over the past year, it has increased by +37.99 (+568.71%). XTLB quarterly interest coverage ratio is now -90.56% below its all-time high of 331.60, reached on 01 March 2009.XTLB Quarterly Interest Coverage Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XTLB Interest Coverage Ratio Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +568.7% |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
XTLB Interest Coverage Ratio High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -45.3% | +107.7% | ||
| 5 y | 5 years | -45.3% | +107.7% | ||
| alltime | all time | -90.6% | +101.1% |
XTL Biopharmaceuticals Interest Coverage Ratio History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | 31.31(-568.7%) |
| Sept 2023 | - | -6.68(-35.6%) |
| June 2023 | - | -10.38(-71.0%) |
| Mar 2023 | - | -35.76(-91.3%) |
| Sept 2022 | - | -409.50(+1543.9%) |
| June 2022 | - | -24.91(-143.5%) |
| Mar 2022 | - | 57.22(-130.0%) |
| June 2021 | - | -190.67(+85.9%) |
| June 2020 | - | -102.56(-169.8%) |
| Mar 2018 | - | 146.83(<-9900.0%) |
| Sept 2017 | - | -0.25(-45.7%) |
| June 2017 | - | -0.46(0.0%) |
| Mar 2017 | - | -0.46(-99.8%) |
| Sept 2016 | - | -285.00(+572.8%) |
| June 2016 | - | -42.36(-85.3%) |
| Mar 2016 | - | -287.50(+4146.7%) |
| Sept 2015 | - | -6.77(-70.8%) |
| Mar 2015 | - | -23.19(+354.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2014 | - | -5.10(-95.7%) |
| Mar 2014 | - | -118.40(-309.1%) |
| Sept 2013 | - | 56.63(-113.7%) |
| June 2013 | - | -413.67(+278.8%) |
| Mar 2013 | - | -109.20(+926.3%) |
| June 2012 | - | -10.64(-97.1%) |
| Mar 2012 | - | -368.00(+6518.7%) |
| Sept 2011 | - | -5.56(-94.1%) |
| June 2011 | - | -94.33(-15.3%) |
| Mar 2011 | - | -111.33(-26.3%) |
| Dec 2010 | -178.57(-169.4%) | -151.00(+53.0%) |
| Sept 2010 | - | -98.67(-68.9%) |
| June 2010 | - | -317.00(-5.4%) |
| Mar 2010 | - | -335.00(-201.0%) |
| Dec 2009 | 257.40(-123.7%) | - |
| Mar 2009 | - | 331.60(-111.7%) |
| Dec 2008 | -1084.76 | -2823.00(+605.8%) |
| Sept 2008 | - | -400.00 |
FAQ
- What is the all time high annual interest coverage ratio for XTL Biopharmaceuticals?
- What is XTL Biopharmaceuticals quarterly interest coverage ratio?
- What is the all time high quarterly interest coverage ratio for XTL Biopharmaceuticals?
- What is XTL Biopharmaceuticals quarterly interest coverage ratio year-on-year change?
What is the all time high annual interest coverage ratio for XTL Biopharmaceuticals?
XTL Biopharmaceuticals all-time high annual interest coverage ratio is 257.40
What is XTL Biopharmaceuticals quarterly interest coverage ratio?
The current quarterly interest coverage ratio of XTLB is 31.31
What is the all time high quarterly interest coverage ratio for XTL Biopharmaceuticals?
XTL Biopharmaceuticals all-time high quarterly interest coverage ratio is 331.60
What is XTL Biopharmaceuticals quarterly interest coverage ratio year-on-year change?
Over the past year, XTLB quarterly interest coverage ratio has changed by +37.99 (+568.71%)